RMD ResMed Inc.

ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day

ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day

  • Surveys found pandemic-related stress and anxiety are the most cited reasons keeping people up at night
  • Quality and quantity of sleep have benefitted from remote working, and many are concerned waking up will be difficult as they return to a physical workplace
  • More than half of Americans report their doctor hasn’t asked them about their sleep health

SAN DIEGO, March 14, 2022 (GLOBE NEWSWIRE) -- ResMed announced today the results of its 2022 Global Sleep Surveys, in conjunction with National Sleep Awareness Week (March 13-19) and World Sleep Day (March 18). The surveys, conducted in the first quarter of the year,1 asked nearly 25,000 respondents in 12 countries what’s keeping them up at night and the results aim to build awareness of the critical role good sleep plays in physical and mental health.

Across most countries, a majority of respondents reported stress has had an impact on their sleep since the start of the pandemic, with a high of 64% in Brazil and a low of 35% in Germany and Japan. In the United States, 38% of respondents cited depression and anxiety as the reasons they do not sleep well at night. Beyond stress, depression, and anxiety, respondents listed family pressures, work-related concerns, and financial pressures as reasons for not sleeping well.

The survey also revealed how returning to the office has impacted the way people believe their sleep quality will change. Many respondents said they have slept better or longer while working remotely and believe more in-office working time will make it difficult to wake up in the morning:

  • 45% of Americans who reported working from home said they get more sleep compared to working in an office, and 48% of those who said they currently work remotely said it will be harder for them to wake up once they return to a physical workplace.
  • Germany (66%), India (65%), China (61%), and Australia (60%) ranked highest in respondents who reported working from home and predicted it will be harder for them to get up in the morning once they transition back to working in an office.

“Getting good quality sleep is a struggle for people across the globe for many different reasons,” said Carlos M. Nunez, M.D., chief medical officer for ResMed. “It is clear that the pandemic has caused an increase in poor quality sleep due to stress, depression, and anxiety, but our survey found that in most countries, nearly half of respondents say they’ve never sought professional medical help to improve their sleep or address underlying issues.”

Sleep Aids and Medications

While sleep health is an important issue, many survey respondents said they’re not consulting with their doctor on solutions to get a better night’s sleep, but rather turning to potentially unhealthy habits such as:

  • Binge-watching television shows to help them fall asleep (23% of Americans, 20% of Germans and British respondents); or
  • Traditional medications or alternative sleep aids such as aromatherapy or tea (29% of Americans).

More than half of Americans say their doctor has never proactively asked them about the quality of their sleep – and that number is even higher across the globe.

Snoring and Sleep Conditions

While everyone experiences a lousy night of sleep occasionally, those who experience ongoing sleep issues could be dealing with a more significant underlying health condition. Approximately 52% of Americans reported snoring or being told they snore, but only 33% are concerned about health implications tied to snoring. People may think they are sleeping soundly when in fact, they are repeatedly and unconsciously waking up throughout the night due to undiagnosed sleep apnea – of which snoring is the number one symptom.

“Sleep quality can be impacted by lifestyle changes and poor habits, but many people are struggling with undiagnosed conditions that may be the root cause,” said Carlos M. Nunez, M.D. “Sleep apnea is a serious health concern, but very few people are screened for the condition which impacts more than 54 million people in the U.S.”2

In America, only 22% of respondents said they have been tested for sleep apnea. That percentage is even lower in other countries: 17% testing in France, 15% in Germany, 13% in the United Kingdom, and 12% in Singapore.

To learn more about the state of sleep health across the globe and sleep apnea, or to take a quick self-assessment for your risk of sleep apnea, visit .

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

1 ResMed 2022 Global Surveys, 23,040 total participants across Australia, Brazil, China, France, Germany, India, Japan, Mexico, Singapore, South Korea, United Kingdom, and United States, conducted from January 19 to February 18, 2022.

2 Benjafield AV et al. Lancet Resp Med 2019

For Media

Kristin Deuber

+1 615.975.4186

For Investors

Amy Wakeham

+1 858.836.5000



EN
14/03/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ResMed Inc.

ResMed Inc: 1 director

A director at ResMed Inc sold 2,000 shares at 260.220USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Pr...

Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains  53% of people surveyed rank sleep as the most important behavior for a long, healthy life, ahead of diet and exercise.Over half of respondents get quality sleep on only four nights a week or less.While 66% of people surveyed say they would seek medical help for ongoing sleep issues, just 23% actually do. SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- ...

 PRESS RELEASE

Resmed Expands U.S. Operations with New Distribution Center in Greenwo...

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana Center to Create Local Jobs and Strengthen U.S. Healthcare Supply Resilience SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, is opening a new distribution center in Greenwood, Indiana. Scheduled to begin operations in 2027, the center will expand Resmed’s U.S. presence and strengthen the company's distribution capacity to better serve patients and providers across North America. The...

 PRESS RELEASE

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 20...

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026 Revenue increased by 11% to $1.4 billion; up 9% on a constant currency basis Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%Income from operations increased 18%; non-GAAP income from operations up 19%Diluted earnings per share of $2.68; non-GAAP diluted earnings per share of $2.81Operating cash flow of $340 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at  SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX: RMD) today an...

 PRESS RELEASE

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 20...

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026 SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:•Location:•Date:Thursday, January 29, 2026•Time:1:30 p.m. PST /...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch